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ScienceDirectLoss of interest in rewarding activities is a hallmark of many
psychiatric disorders and may be relevant for
neurodegenerative disorders and patients suffering from brain
injury. There is increasing evidence that deficits in reward-
related behaviour are more complex than previously described.
The traditional view of anhedonia as ‘the inability to experience
pleasure’ may be too limited to fully encompass the types of
reward deficit observed in these patients. Developments in
methods to measure different aspects of reward processing in
humans and animals are starting to provide insights into the
complexity of this behaviour. In this article we consider the
rodent models which have traditionally been used to study
reward deficits in psychiatric disorders and consider their
limitations relative to clinical findings. We then discuss work
where methods derived from human neuropsychological tests
are providing insights into the complexity of reward-related
behaviour. Specifically, we consider tasks which investigate
different aspects of reward-related behaviour focusing on
learning and memory as well as decision-making and consider
what these may mean in terms of how we model reward deficits
in rodents.
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Introduction
Deficits in reward processing are observed across a range
of psychiatric disorders [1–6]. More broadly, impair-
ments in reward processing may contribute to the
observed motivational deficits, loss of interest in social
interaction, and apathy. Whilst reward deficits are clearly
an important feature of these clinical conditions, there
are currently no treatments which specifically target
these symptoms. Animal models are an important ele-
ment of aetiological studies and drug development pro-
grammes. However, using animals to study complex
human psychological symptoms is often challenging.Current Opinion in Behavioral Sciences 2018, 22:136–142 In this article, we consider why traditional consumma-
tory and motivational tests for anhedonia may be limited
in terms of providing a valid translational approach to
studying the reward deficits that are most prevalent in
these different patient populations. We also consider
whether new tasks, which look at more complex proces-
sing of reward information, may provide a better
approach. Specifically, we discuss new data from models
looking at reward learning and decision-making as well
as studies where biases in reward-related behaviour have
been linked to changes in affective state.
What is anhedonia?
Historically, anhedonia was defined as an ‘inability to
experience pleasure’ [7]. However, in the last 20 years,
knowledge relating to the neurobiology of reward and
how we consider this in relation to anhedonia has devel-
oped. This has resulted in a growing interest in how we
define anhedonia and consequently how we model this
in rodents. Whilst the exact definitions are debated (see
Table 1 and review articles [8–11,12,13,14]), it is sug-
gested that symptoms of anhedonia observed in patients
may be due to deficits in one or several different com-
ponents of reward processing: firstly, consummatory
experience of reward, secondly motivation for reward,
thirdly reward learning and finally decision making. In
relation to major depressive disorder, impairments in
reward-related behaviour are more broadly set out in the
DSM-5 as a ‘loss of interest or pleasure in previously
rewarding activities’. Reward-related behavioural defi-
cits are also considered within the recent concept of
Research Domains Criteria (RDoC) framework for men-
tal health research [15–17]. The positive valance system
makes up one of the key domains which has been
included in this framework. In this article, we will focus
our discussion on methods to assess these different
subcomponents of reward (see Figure 1, panel a for
summary). We briefly discuss why traditional consum-
matory and motivational tests for anhedonia may be
limited in terms of providing a valid translational
approach to studying the reward deficits that are most
prevalent in different patient populations. We also dis-
cuss whether recently developed methods looking at
reward learning, memory and decision-making may pro-
vide a better approach. Specifically, we discuss new data
from behavioural tasks which have been looking at
reward learning and decision-making as well as studies
where biases in reward-related cognition have been
linked to changes in the emotional state of the animal,
more commonly referred to as affective state in non-
human species.www.sciencedirect.com
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Table 1
Summary of some of the key papers relating to the discussions about how we define anhedonia and reward-related deficits in psychiatric
disorders [7,8,9,12,13,14]
Year Definition of anhedonia Reference
1896 ‘The inability to experience pleasure’ Ribot (1896)
2003 Liking
Wanting
Robinson and Berridge (2003)
2008 Liking, wanting, learning (pleasure cycle = appetitive, consummatory and satiety Berridge and Kringelbach (2008)
2011 Distinction between consummatory, motivational and decision-making Treadway and Zald (2011)
2012 Distinction between anhedonia and cognitive aspects of reward Der-Avakian and Markou (2012)
2015 ‘Impairments in the ability to pursue, experience and/or learn about pleasure’ Thomsen (2015)Limitations associated with consummatory
and motivational deficits in reward-related
behaviour in rats
Most studies investigating reward processing in rodents
have used tasks based on consummatory behaviour
(hedonia) and motivation for reward (see
[1,2,12,13,14,18,19] for detailed review of relevant meth-
odology). For example, reward sensitivity can be mea-
sured directly using intracerebral self-stimulation meth-
ods where deficits resulting from chronic stress are
observed as an increase in the stimulation threshold
[20]. A simpler and more commonly used method to
study anhedonia, particularly for depression research,
has been the sucrose preference test (SPT) where the
ability of an animal to detect and show a preference for a
weak sucrose or saccharin solution over water is measured
[21]. Animals in putative negative affective states follow-
ing exposure to chronic stress show a reduced sucrose
preference [21–23]. However, not all depression models
show impairments in the SPT and studies in Schizophre-
nia models also fail to observe deficits [1,24]. Additionally,
in the human literature, depressed patients do not exhibit
deficits in a similar sweet taste test [25,26] suggesting
limited translational validity of the SPT.
Motivation for reward tasks, such as progressive ratio and
effort-based tasks, provide an alternative method to study
reward-related behaviours [15,27]. In the progressive ratio
task, over several trials rats are required to perform
incrementally higher operant responses (e.g. press a lever)
in order to obtain the same amount of reward. Motivation
in this task is determined as the point at which rats stop
responding (i.e. their ‘breakpoint’). Whilst this task dis-
plays reasonable translational validity, with both humans
and rodents displaying motivational deficits related to
dopamine depletion [28–30] models of depression (e.g.
chronic mild stress and maternal separation) and other
psychiatric disorders in rodents display less consistent
changes in motivation [31,32,33], although also see [34].
In progressive ratio tasks, increased effort (number of
responses) is also associated with an increase in time to
obtain reward and therefore may be confounded by motor
impairments. There is also the potential for animal’s
tolerance to delayed reward to contribute to behaviouralwww.sciencedirect.com outcomes which, whilst potentially of interest, may relate
more to neural circuits modulating impulse control as
opposed to reward. Because of the limitations of the
standard progressive ratio task, effort-based choice tasks
have been developed where animals are required to
choose between an easy to obtain low-value reward versus
a high-value/high-effort reward [5,35,36,37,38,39].
This task requires the animal to make a choice based
on motivation for the different reward option and hence
also models decision-making behaviour. Validation of the
model is still limited but there is a clear translational
advantage with similar human methods now being used
[40]. More detailed discussion about these tasks and their
associated psychopharmacology are reviewed in
[1,18,38,40].
New developments in methods to study
reward-related cognition and affective biases
Advances in measuring reward-related behaviour in
humans, such as the move away from subjective, ques-
tionnaire-based methods and the development of com-
puter-based neuropsychological tasks, have supported
reverse translation into animal research. An excellent
example of this is the probabilistic reward learning task
[41–43] and probabilistic reversal learning task [44,45]. In
both models, the animal is required to learn contingencies
associated with different cues despite receiving false
feedback resulting from the probabilistic nature of the
reward delivery. Probability of reward can be altered to
increase task difficulty, and response bias, discriminabil-
ity, accuracy, reaction time and sensitivity to positive and
negative feedback can all be collected. Tasks using
operant chambers with spatial cues or tones, a touchsc-
reen task and methods using odour cues have all been
piloted [1,43]. However, it should be noted that there are
marked differences between human and rat data in terms
of the proportion of lose-shift responses after misleading
negative feedback suggesting the underlying biology may
be different.
In our own laboratory, we started looking at how affective
states could modify reward learning as part of our research
into affective biases [46,47]. Affective bias is a term used
to describe how affective states influence cognitiveCurrent Opinion in Behavioral Sciences 2018, 22:136–142
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Rodent tasks which provide quantified measures of the different aspects of reward processing have been developed. Summarised in table (a) are
examples of these different methods. Recent developments have seen a shift from the more typical measures of reward deficits based on
changes in hedonia or motivation to methods which measure the cognitive aspects of reward such as learning memory and decision-making.
Panels (b,c) illustrate two tasks which we have recently developed to study how reward-related behaviour is altered by affective state. The
affective bias test is used to study biases in reward learning and memory and the judgement bias task which provides a method to study
interpretation biases in the interpretation of ambiguous information and an animal’s anticipation of positive or negative outcomes. Panel (b)
illustrates the ABT method and some of the data obtained following manipulations administered during the learning phase of the task only
(acquisition and consolidation). We can also test how these biases are subsequently modulated by also administering treatments before the
preference test (recall) to determine if they alter the previously learnt bias. These studies have revealed that antidepressant and pro-depressant
manipulations induce a subsequent bias in the reward-related memory. Following induction of a negative bias, pre-treatment with ketamine but
not the conventional antidepressant venlafaxine results in an attenuation of the bias suggesting these different types of antidepressant can
differentially modulate reward-related learning and memory. Dissociable effects between conventional and rapid onset antidepressants have also
been observed in the judgement bias task with evidence of difference in the time course of effects. As illustrated in panel (c), the judgement bias
task involves first training animals in an operant task where responses to obtain different values of reward, (or reward versus punishment
avoidance) are first trained. Animals’ interpretation biases are then probes using a testing phase where both reference and intermediate
ambiguous cues are presented, and the animals responses recorded. In this measure of reward-related decision-making, chronic but not acute
treatment with antidepressants induces a shift in decision-making biases. In contrast, ketamine induces an immediate positive bias suggesting
different underlying mechanisms of action which may help explain the temporal differences observed with these treatments in patients. More
details of the methods for the affective bias test and judgement bias task are discussed in the main text.processes to bias responding. Biases have been observed
across many different cognitive domains with clinical
studies demonstrating impairments in emotional inter-
pretation, memory and decision-making, and in response
to acute doses of antidepressants [48–51,52]. To translateCurrent Opinion in Behavioral Sciences 2018, 22:136–142 this work to animals, we needed to use stimuli and out-
comes appropriate to the species [53]. This was
achieved by pairing previously neutral cues with emo-
tionally-valenced outcomes: obtaining reward or avoiding
punishment. The use of reward-related learning andwww.sciencedirect.com
Rat models of reward Slaney, Hales and Robinson 139memory in these tasks, as well as decision-making behav-
iour, has led to new insights into how these are modified
in psychiatric disorders.
The affective bias test (ABT, Figure 1, panel b) was
designed to investigate how affective state at the time of
learning would impact on the subsequent reward value
attributed to the memory of that experience [54]. Animals
are first presented with a simple task where they are
required to learn the association between a specific cue (a
digging substrate) and a rewarding outcome (a food
pellet). These Pavlovian associations are leant on inde-
pendent days with the reward value kept constant, but a
manipulation can be applied before one of the cue-reward
associations. Because of the within-subject design, a
subsequent choice test can be used to assess the individ-
ual animal’s preference between the two previously learnt
reward-associated cues. Where the manipulation leads to
a positive affective state, animals show a preference for
the reward-cue paired during treatment versus the cue
paired during the control condition, a positive bias [54–
56]. The opposite is seen with manipulations which
induce a negative affective state, or are pro-depressant,
with animals biasing their responding away from the
treatment-paired cue [54,55,57]. Importantly, positive
biases are seen with acute antidepressant treatment
whilst negative biases are observed following treatments
known to have pro-depressant effects (Figure 1, panel b,
effect on acquisition and consolidation). Administering
treatments immediately post discrimination learning
showed similar effects, suggesting consolidation is the
most likely aspect of learning being modulated [54].
Interestingly, we did not find any effects with dopami-
nergic drugs, suggesting a distinct underlying neurobiol-
ogy [54]. Further studies have linked the modulation of
reward-learning in this task to the amygdala [58]. Whilst
the amygdala is known to play a role in Pavlovian condi-
tioning, we observe an interesting dissociation between
biases induced by manipulations of affective state (atten-
uated) versus those induced by changes in absolute
reward (not affected).
To test whether these treatment-induced biases can be
subsequently altered, we can also administer a treatment
immediately before the choice test (Figure 1, panel b,
effect on recall, [58]). In this version of the ABT, we
observe an interesting dissociation between delayed and
rapid onset antidepressants [58]. The NMDA antagonist,
ketamine but not the monoaminergic antidepressant,
venlafaxine, was able to attenuate previously learnt biases
which we propose may help explain its rapid onset of
action. We linked this effect to the medial prefrontal
cortex where inactivation using the GABA agonist mus-
cimol induced similar effects. To date, we have shown
that the ABT can provide a novel method to study how
manipulations at the time of learning can impact on long
term memory for reward and how this influenceswww.sciencedirect.com behaviour when the animal re-encounters the cue which
predicts that specific reward.
The assay may also be interesting for research relating to
the learning of rewards of different absolute values, an
aspect of reward-related cognition which is not currently
addressed within the basic research field. We made some
early attempts to test this by developing a modified
version of the assay which measures associations between
distinct, independently learnt cues that predict different
values of reward [57]. We have termed this a reward-
induced positive bias and normal animals show a bias
towards the cue paired with a higher value reward. Initial
studies have focussed on putative models of depression
and we have observed significant deficits in reward mem-
ory when animals are treated with chronic corticosterone,
chronic pro-depressant drug treatments and in animals
exposed to early life adversity [59]. Importantly, this
effect is distinct from consummatory deficits as, with the
exception of the chronic corticosterone treatment, the
same animals do not show impairments in the SPT [59].
A similar deficit in reward-induced positive bias has also
been observed in the sub-chronic PCP model of schizo-
phrenia which similarly does not show impaired reward-
related behaviour in other methods [60].
Another task which investigates affective biases, but this
time in relation to reward-related decision-making, is the
judgement bias task [46,61]. The task tests whether the
affective state of an animal biases decisions-making dur-
ing presentation of ambiguous information. There have
been two different versions developed which either use
reward versus punishment avoidance or high-reward
versus low-reward ([46], see Figure 1, panel c). Animals
are first trained to associate specific cues (reference cues)
with predicting a high-value or low-value reward (or
avoidance of punishment). Once a stable baseline level
of responding has been achieved, the animals are pre-
sented with intermediate ambiguous cues and their
responses (anticipation of high-value or low-value reward)
used to indicate a positive or negative bias. Both versions
of the task have shown that animals in a putative negative
affective state are more likely to anticipate a less positive
or negative event [61–68]. Pharmacological studies have
revealed an interesting dissociation between acute and
chronic effects of monoaminergic antidepressants, with
effects only observed following chronic administration
[64]. In contrast, the rapid-onset antidepressant ketamine
induces an immediate positive bias [64]. A major advan-
tage of the judgement bias task is its ability to differenti-
ate between biases in decision-making (responses made
to ambiguous probe cues) and changes in consummatory
or motivational aspects of reward (responses made to
reference cues). In our studies, we have been able to
demonstrate specific changes in decision-making behav-
iour without effects on consummatory or motivational
measures [63,64].Current Opinion in Behavioral Sciences 2018, 22:136–142
140 Apathy and motivationConclusions
Deficits in reward processing are no longer considered a
unitary construct and these new developments in animal
models support this. A patient may report a loss of interest
in pleasurable activities, but the underlying cause of this
deficit may lie within one or more of several distinct
domains which ultimately contribute to reward-related
behaviour. Questionnaire measures are limited in terms
of their ability to differentiate between these different
subcomponents. To address this, new translational meth-
ods to study reward-related cognition in both human and
animal studies have been developed and are starting to
yield important findings. Further studies comparing dif-
ferent patient populations using a test battery designed to
probe different types of reward deficit are needed. Simi-
larly, more detailed validation of the rodent tasks dis-
cussed here are required, particularly to extend the find-
ings from depression-related research to other areas
including other psychiatric disorders and neurodegenera-
tive conditions. On the basis of clinical findings, impair-
ments in reward-related cognition may represent a more
relevant phenotype and the new tasks discussed here
offer a pre-clinical approach to study these.
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